Graft-versus-host Disease: Role of inflammation in the development of chromosomal abnormalities of keratinocytes

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 12, 2010, Pages 1665-1673

  Sloand, Elaine M ^a   Pfannes, Loretta ^a   Ling, Casey ^a   Feng, Xingmin ^a   Jasek, Monika ^a   Calado, Rodrigo ^a   Tucker, Zachary C G ^a   Hematti, Peiman ^a   Maciejewski, Jaroslaw ^a   Dunbar, Cynthia ^a   Barrett, John ^a   Young, Neal ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Aneuploidy; Genomic instability; Inflammation; Keratinocytes; Squamous cell carcinoma; Tetraploidy

Indexed keywords

CD40 LIGAND; CXCL11 CHEMOKINE; CYCLOPHOSPHAMIDE; EOTAXIN; EPIDERMAL GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FLUDARABINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN P53; RANTES; SCATTER FACTOR; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIVISION; CHROMOSOME 17; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; INFLAMMATION; KERATINOCYTE; LYMPHOCYTE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; POLYMERASE CHAIN REACTION; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; TETRAPLOIDY; WHOLE BODY RADIATION;

ADULT; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; COCULTURE TECHNIQUES; FEMALE; GENES, P53; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; KERATINOCYTES; LEUKEMIA; LYMPHOCYTES; MALE; MIDDLE AGED; PLOIDIES; SKIN NEOPLASMS; TELOMERE; YOUNG ADULT;

EID: 78149410631     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.07.014     Document Type: Article

References (50)

1. Bhatia S., Louie A.D., Bhatia R., et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001, 19:464-471.
2. Ramsay H.M., Reece S.M., Fryer A.A., Smith A.G., Harden P.N. Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. Renal transplant recipients. Transplantation 2007, 84.
3. Socie G., Curtis R.E., Deeg H.J., et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000, 18:348.
4. Ulrich C., Kanitakis J., Stockfleth E., Euvrard S. Skin cancer in organ transplant recipients-where do we stand today?. Am J Transplant 2008, 8:2192-2198.
5. Rizzo J.D., Curtis R.E., Socie G., et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009, 113:1175-1183.
6. Travis L.B., Hill D.A., Dores G.M., et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003, 290:465-475.
7. Curtis R.E., Metayer C., Rizzo J.D., et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005, 105:3802-3811.
8. Dantal J., Hourmant M., Cantarovich D., et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998, 351:623-628.
9. Otley C.C., Maragh S.L. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005, 31:163-168.
10. Svendsen L.B., Larsen J.K., Christensen I.J. Human skin fibroblast in vitro tetraploidy. Flow cytometric DNA assay used to confirm metaphase assay in patients with various colonic diseases. Cancer Genet Cytogenet 1989, 39:245-251.
11. Maley C.C., Galipeau P.C., Li X., et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 2004, 64:7629-7633.
12. Sherman M. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment. Cleve Clin J Med 2009, 76(Suppl 3):S6-S9.
13. Marnett L.J., Riggins J.N., West J.D. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 2003, 111:583-593.
14. West J.D., Marnett L.J. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol 2006, 19:173-194.
15. West J.D., Ji C., Marnett L.J. Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1. J Biol Chem 2005, 280:15141-15147.
16. Marnett L.J., Plastaras J.P. Endogenous DNA damage and mutation. Trends Genet 2001, 17:214-221.
17. Galipeau P.C., Li X., Blount P.L., et al. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med 2007, 4:e67.
18. Lalwani N.D., Dethloff L.A., Haskins J.R., Robertson D.G., De La Iglesia F.A. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver. Toxicol Pathol 1997, 25:165-176.
19. Lothschutz D., Jennewein M., Pahl S., et al. Polyploidization and centrosome hyperamplification in inflammatory bronchi. Inflamm Res 2002, 51:416-422.
20. Rodin S.N., Rodin A.S. Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol 2005, 15:103-112.
21. Goodman J.E., Hofseth L.J., Hussain S.P., Harris C.C. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 2004, 44:3-9.
22. Ambs S., Hussain S.P., Marrogi A.J., Harris C.C. Cancer-prone oxyradical overload disease. IARC Sci Publ 1999, 295-302.
23. Hussain S.P., Harris C.C. p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis. J Nippon Med Sch 2006, 73:54-64.
24. Ganem N.J., Storchova Z., Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007, 17:157-162.
25. Dabelsteen S., Hercule P., Barron P., Rice M., Dorsainville G., Rheinwald J.G. Epithelial cells derived from human embryonic stem cells display P16(INK4A) senescence, hypermotility, and differentiation properties shared by many P63(+) somatic cell types. Stem Cells 2009, 27:1388-1399.
26. Hofseth L.J., Saito S., Hussain S.P., et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 2003, 100:143-148.
27. Ozturk K., Acar H., Durmus E., Ozturk A., Mutlu N. Analysis of chromosomes 8 and 17 aneuploidies in laryngeal squamous cell carcinoma by fluorescence in situ hybridization. Laryngoscope 2004, 114:1005-1010.
28. Tralongo V., Rodolico V., Luciani A., Marra G., Daniele E. Prognostic factors in oral squamous cell carcinoma. A review of the literature. Anticancer Res 1999, 19:3503-3510.
29. Akrish S., Buchner A., Dayan D. Oral cancer: diagnostic options as an aid to histology in order to predict patients at high risk for malignant transformation. Refuat Hapeh Vehashinayim 2004, 21:6-15. 93.
30. Goldsmith M.M., Cresson D.H., Arnold L.A., Postma D.S., Askin F.B., Pillsbury H.C. DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 1987, 96:307-318.
31. Ravindran A., Vijayakumar T., Sudha L., et al. Chromosome abnormalities in squamous cell carcinoma of the human oral cavity. Neoplasma 1990, 37:191-197.
32. Robinson J.K., Rademaker A.W., Goolsby C., Traczyk T.N., Zoladz C. DNA ploidy in nonmelanoma skin cancer. Cancer 1996, 77:284-291.
33. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000, 36:311-327.
34. Struikmans H., Rutgers D.H., Hordijk G.J., Slootweg P.J., van der Tweel I., Battermann J.J. Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors. Int J Radiat Oncol Biol Phys 1998, 40:27-34.
35. Hematti P., Sloand E.M., Carvallo C.A., et al. Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation. Exp Hematol 2002, 30:943-949.
36. Zhao L., Khan Z., Hayes K.J., Glassman A.B. Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12. Ann Clin Lab Sci 1998, 28:51-56.
37. Klimczak A., Lange A. Apoptosis of keratinocytes is associated with infiltration of CD8+ lymphocytes and accumulation of Ki67 antigen. Bone Marrow Transplant 2000, 26:1077-1082.
38. Olaharski A.J., Sotelo R., Solorza-Luna G., et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 2006, 27:337-343.
39. McNamee L.M., Brodsky M. p53-Independent apoptosis limits DNA damage-induced aneuploidy. Genetics 2009, 182:423-435.
40. Borel F., Lohez O.D., Lacroix F.B., Margolis R.L. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc Natl Acad Sci USA 2002, 99:9819-9824.
41. Lechel A., Holstege H., Begus Y., et al. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease. Gastroenterology 2007, 132:1465-1475.
42. Schwartz J.L., Jordan R., Liber H., Murnane J.P., Evans H.H. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines. Genes Chromosomes Cancer 2001, 30:236-244.
43. Kammori M., Poon S.S., Nakamura K., et al. Squamous cell carcinomas of the esophagus arise from a telomere-shortened epithelial field. Int J Mol Med 2007, 20:793-799.
44. Kinouchi Y., Hiwatashi N., Chida M., et al. Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol 1998, 33:343-348.
45. Lee Y.H., Oh B.K., Yoo J.E., et al. Chromosomal instability, telomere shortening, and inactivation of p21WAF1/CIP1 in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol 2009, 22:1121-1131.
46. Kitay-Cohen Y., Goldberg-Bittman L., Hadary R., Fejgin M.D., Amiel A. Telomere length in Hepatitis C. Cancer Genet Cytogenet 2008, 187:34-38.
47. Griffith J.K., Bryant J.E., Fordyce C.A., Gilliland F.D., Joste N.E., Moyzis R.K. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Res Treat 1999, 54:59-64.
48. Blasco M.A., Lee H.W., Hande M.P., et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
49. Krunic D., Moshir S., Greulich-Bode K.M., et al. Tissue context-activated telomerase in human epidermis correlates with little age-dependent telomere loss. Biochim Biophys Acta MolBasis Dis 2009, 1792:297-308.
50. Storchova Z., Kuffer C. The consequences of tetraploidy and aneuploidy. J Cell Sci 2008, 121:3859-3866.